GuidelineEuropean journal of nuclear medicine and molecular imaging2023
The EANM guideline on radioiodine therapy of benign thyroid disease.
Guideline in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06868459 (Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it.
- 2025 Korean Thyroid Association Management Guidelines for Radioactive Iodine Therapy in Patients with Hyperthyroidism.Endocrinology and metabolism (Seoul, Korea) · 2025Guideline
- From Patient Selection to Surveillance: Artificial Intelligence Applications in Radioiodine Therapy - A Systematic Review.Nuclear medicine and molecular imaging · 2026Review
- Severe symptomatic hypocalcemia with probable transient parathyroid dysfunction following radioiodine therapy for Graves' disease: a case report.Oxford medical case reports · 2026Article
- Tomographic 3D Ultrasound for Thyroid Volumetry-A Comparison Between Multiplanar 2D and 3D Imaging Methods.Diagnostics (Basel, Switzerland) · 2026Article
- Article
- Article
- Combating radiophobia: a top priority for the further development of nuclear medicine.EJNMMI reports · 2026Article
- Multiple machine learning models for the prediction of an early response to radioactive iodine therapy in hyperthyroidism: ablative dose concept.Thyroid research · 2026Article
- Marine-Lenhart syndrome: why nuclear medicine imaging remains essential for diagnosis and treatment.European journal of nuclear medicine and molecular imaging · 2026Review
- Disulfiram metabolite Cu(DDC)EBioMedicine · 2026Article
- Case Report: Synchronous primary lung and thyroid cancers - management informed by multimodal imaging and pathologic correlation.Frontiers in oncology · 2026Article
- Preliminary volume-based optimization of radioactive iodine dose without radioactive iodine uptake in Graves' disease.Frontiers in endocrinology · 2026Article
- Predictive factors for the efficacy of radioiodine therapy in patients with Graves' disease.Nuclear medicine communications · 2025Article
- Prolonged Normal Thyroid Function AfterJournal of clinical medicine · 2025Article
- Article
- Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?Journal of endocrinological investigation · 2025Review
- Low risk of thyroid eye disease (TED) following radioiodine (RAI) therapy in a multidisciplinary setting: a retrospective cohort study.Thyroid research · 2025Article
- Challenges in the dose calculation from urine measurements in routine internal monitoring ofRadiation and environmental biophysics · 2025Article
- Primary hyperparathyroidism in a domestic shorthair cat following IThe Journal of small animal practice · 2025Article
- The Impact of Radioiodine (131I) Therapy of Thyroid Disease on Salivary Glands Function and Inflammation: A Comprehensive Review.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients' preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.